SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001746473-21-000005
Filing Date
2021-05-10
Accepted
2021-05-10 16:49:25
Documents
16
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plrx-20210510.htm   iXBRL 8-K 39852
2 EX-99.1 plrx-8kxexhibit991.htm EX-99.1 79154
8 GRAPHIC image_01.jpg GRAPHIC 13148
  Complete submission text file 0001746473-21-000005.txt   293383

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20210510.xsd EX-101.SCH 2423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20210510_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20210510_def.xml EX-101.DEF 1643
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20210510_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20210510_pre.xml EX-101.PRE 13187
9 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20210510_htm.xml XML 11806
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 21908013
SIC: 2834 Pharmaceutical Preparations